Cyclo Therapeutics, Inc.
CYTH · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $928 | $1,122 | $2,995 | $9,247 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $188 | $84 | $71 | $122 |
| Inventory | $236 | $241 | $243 | $254 |
| Other Curr. Assets | $1,905 | $3,004 | $3,261 | $2,695 |
| Total Curr. Assets | $3,257 | $4,450 | $6,570 | $12,318 |
| Property Plant & Equip (Net) | $27 | $268 | $594 | $929 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,971 | $0 | $0 | $0 |
| Total NC Assets | $1,997 | $268 | $594 | $929 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,254 | $4,718 | $7,164 | $13,248 |
| Liabilities | – | – | – | – |
| Payables | $5,023 | $3,860 | $3,671 | $4,857 |
| Short-Term Debt | $12,198 | $2,985 | $648 | $2,021 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $369 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,499 | $2,984 | $2,218 | $1,590 |
| Total Curr. Liab. | $18,720 | $9,829 | $6,536 | $8,468 |
| LT Debt | $7 | $12 | $18 | $45 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | -$22 |
| Total NC Liab. | $7 | $12 | $18 | $22 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $27 | $286 | $665 | $1,033 |
| Total Liabilities | $18,727 | $9,841 | $6,554 | $8,491 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$103,014 | -$94,181 | -$88,200 | -$83,857 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $89,538 | $89,055 | $88,807 | $88,611 |
| Total Equity | -$13,473 | -$5,123 | $610 | $4,757 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,254 | $4,718 | $7,164 | $13,248 |
| Net Debt | $11,277 | $1,875 | -$2,330 | -$7,180 |